Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 15 studies | 26% ± 8% | |
| astrocyte | 14 studies | 37% ± 15% | |
| glutamatergic neuron | 10 studies | 41% ± 25% | |
| type I pneumocyte | 7 studies | 20% ± 5% | |
| epithelial cell | 6 studies | 38% ± 13% | |
| GABAergic neuron | 6 studies | 41% ± 21% | |
| oligodendrocyte | 6 studies | 25% ± 7% | |
| macrophage | 6 studies | 22% ± 4% | |
| neuron | 5 studies | 28% ± 9% | |
| microglial cell | 5 studies | 23% ± 4% | |
| oligodendrocyte precursor cell | 5 studies | 28% ± 10% | |
| goblet cell | 5 studies | 23% ± 12% | |
| interneuron | 5 studies | 36% ± 21% | |
| myeloid cell | 4 studies | 20% ± 4% | |
| fibroblast | 4 studies | 19% ± 3% | |
| endothelial cell of lymphatic vessel | 4 studies | 22% ± 4% | |
| classical monocyte | 3 studies | 23% ± 6% | |
| basal cell | 3 studies | 31% ± 12% | |
| ciliated cell | 3 studies | 26% ± 7% | |
| lymphocyte | 3 studies | 22% ± 1% | |
| type II pneumocyte | 3 studies | 23% ± 3% | |
| abnormal cell | 3 studies | 24% ± 8% | |
| ependymal cell | 3 studies | 37% ± 17% | |
| monocyte | 3 studies | 18% ± 2% | |
| enteroendocrine cell | 3 studies | 18% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| bladder | 100% | 3230.24 | 21 / 21 | 100% | 29.83 | 504 / 504 |
| esophagus | 100% | 3454.04 | 1445 / 1445 | 100% | 51.18 | 183 / 183 |
| intestine | 100% | 3438.91 | 966 / 966 | 100% | 34.39 | 527 / 527 |
| lung | 100% | 3396.63 | 578 / 578 | 100% | 36.24 | 1155 / 1155 |
| prostate | 100% | 2770.08 | 245 / 245 | 100% | 25.41 | 502 / 502 |
| stomach | 100% | 2907.78 | 359 / 359 | 100% | 37.96 | 286 / 286 |
| brain | 100% | 4523.31 | 2641 / 2642 | 100% | 41.83 | 705 / 705 |
| thymus | 100% | 2957.22 | 653 / 653 | 100% | 26.10 | 604 / 605 |
| uterus | 100% | 3443.39 | 170 / 170 | 100% | 28.90 | 458 / 459 |
| ovary | 100% | 2320.82 | 180 / 180 | 100% | 26.84 | 429 / 430 |
| breast | 100% | 2777.78 | 459 / 459 | 100% | 44.21 | 1115 / 1118 |
| skin | 100% | 4260.75 | 1809 / 1809 | 100% | 26.30 | 470 / 472 |
| kidney | 100% | 3038.63 | 89 / 89 | 99% | 30.84 | 896 / 901 |
| pancreas | 100% | 2130.65 | 327 / 328 | 99% | 28.55 | 177 / 178 |
| adrenal gland | 100% | 2409.94 | 258 / 258 | 95% | 14.96 | 219 / 230 |
| liver | 100% | 1410.22 | 226 / 226 | 93% | 13.40 | 376 / 406 |
| adipose | 100% | 2958.93 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 2934.39 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 17.64 | 29 / 29 |
| spleen | 100% | 3586.24 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 31.82 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 17.00 | 1 / 1 |
| eye | 0% | 0 | 0 / 0 | 99% | 21.36 | 79 / 80 |
| heart | 98% | 1415.09 | 844 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 96% | 2819.18 | 896 / 929 | 0% | 0 | 0 / 0 |
| muscle | 94% | 1048.96 | 751 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0005829 | Cellular component | cytosol |
| GO_0005856 | Cellular component | cytoskeleton |
| GO_0005515 | Molecular function | protein binding |
| GO_0003779 | Molecular function | actin binding |
| Gene name | WIPF2 |
| Protein name | WAS/WASL interacting protein family member 2 WAS/WASL interacting protein family member 2 (cDNA FLJ30495 fis, clone BRAWH2000323, moderately similar to WIP-related protein) WAS/WASL-interacting protein family member 2 (WASP-interacting protein-related protein) (WIP- and CR16-homologous protein) (WIP-related protein) |
| Synonyms | PP10631 WIRE WICH |
| Description | FUNCTION: Plays an active role in the formation of cell surface protrusions downstream of activated PDGFB receptors. Plays an important role in actin-microspike formation through cooperation with WASL. May cooperate with WASP and WASL to induce mobilization and reorganization of the actin filament system. . |
| Accessions | J3KSA3 J3QQS0 ENST00000582781.5 J3QKM5 ENST00000583268.1 ENST00000584296.1 ENST00000394103.7 A8MWR2 ENST00000583130.5 [Q8TF74-1] Q8TF74 ENST00000585043.5 [Q8TF74-1] ENST00000323571.9 [Q8TF74-1] |